Background: This descriptive study aimed to assess the survival rates and outcomes of dental implants in one of the four national HMOs in Israel. Data are provided for the period from 1 January 2014 to 31 December 2022. Materials and Methods: This retrospective analysis utilized electronic medical records of patients who underwent dental implant placement during the specified period. Statistical analyses included chi-squared tests, Student’s t-tests, and generalized estimating equation (GEE) analyses to identify potential risk factors associated with early and late implant failures. Results: A total of 158,824 dental implants were placed in 53,874 patients. The overall implant failure rate was 2.21%, while the early failure rate during the osseointegration phase—before prosthetic reconstruction—was 1.56%. Significant associations with implant failure were observed for male patients (2.53% failure rate), implants in the maxillary molar region (3%), and the central incisor region (3.37%), approximately double the failure rates seen in other implant sites (p < 0.001). Conclusions: This extensive data analysis demonstrates a low overall failure rate for dental implants. The highest failure incidence occurred within the first year post-implantation, declining in subsequent years irrespective of rehabilitation status. Early failure risk factors differ based on various factors and should be carefully integrated into presurgical planning.
Objective: To evaluate the clinical success outcomes and risk factors associated with dental implants placed with simultaneous bone augmentation in a large-scale, real-world cohort. Methods: A retrospective analysis was conducted on 158,824 implants, including 45,715 Dental Bone Grafts, placed between 2014 and 2022 within a national healthcare network. Multivariate Generalized Estimating Equations were utilized to assess the impact of demographic, anatomical, and procedural variables on implant failure. Results: The augmented cohort demonstrated a high clinical success rate of 97.83% (2.17% failure), statistically comparable to the general implant population. Failures were predominantly early (<1 year), accounting for 70% of losses. Significant independent risk factors included immediate implant placement (3.08% failure vs. 2.07% for delayed), male gender, and maxillary location. Notably, low socioeconomic status (SES) emerged as a significant predictor, with a failure rate of 3.07% compared to 2.06% in high-SES groups. Conclusions: Simultaneous bone augmentation is a predictable modality that does not inherently increase implant failure risk, supporting the stabilization hypothesis. However, failure is modulated by specific variables. The identification of lower SES, male gender, and immediate placement as significant risk indicators highlights the necessity for personalized risk assessment and targeted protocols to optimize outcomes in augmented sites.
Tooth decay, also known as caries, is a significant medical problem that harms teeth. Treatment is based on the removal of the carious material and then filling the cavity left in the tooth, most commonly with amalgam or composite resin. The consequences of filling failure include repeating the filling or performing another treatment such as a root canal or extraction. Dental amalgam contains mercury, and there is a global effort to reduce its use. However, no consensus has been reached regarding whether amalgam or composite resin materials are more durable, and which is the best restorative material, when using randomized clinical trials. To determine which material is superior, we performed a retrospective cohort study using a large database where the members of 58 dental clinics with 440 dental units were treated. The number of failures of the amalgam compared to composite resin restorations between 2014 and 2021 were compared. Our data included information from over 650,000 patients. Between 2014–2021, 260,905 patients were treated. In total, 19,692 out of the first 113,281 amalgam restorations failed (17.49%), whereas significantly fewer composite restorations failed (11.98%) with 65,943 out of 555,671. This study indicates that composite is superior to amalgam and therefore it is reasonable to cease using mercury-containing amalgam.
Background: Tooth loss causes alveolar bone resorption, which may hinder the ability of implant placement. Socket preservation with immediate implant placement is one of the methods used to reduce bone resorption. In this retrospective study, we evaluated the influence of the use of dense polytetrafluoroethylene (d-PTFE) membranes on alveolar preservation after tooth extraction and with the installation of immediate dental implants. Methods: In this retrospective study, one hundred and four patients were divided into two groups: immediate implant and gap filling with heterogenous bone graft (control group, 52 patients) or immediate implant, gap filling with heterogenous bone graft, and covering with a d-PTFE membrane with dimensions of 12 × 24 mm, which was intentionally left exposed to the oral cavity (test group, 52 patients). Tomographic data were obtained before and 12 months after the surgical procedures. Results: The membranes exposed in the oral cavity showed no infection. Volumetric analyses revealed a statistically significant difference in alveolar ridge resorption for the control and d-PTFE groups, 16.75% and 4.55%, respectively. Conclusions: Intentionally exposed d-PTFE membranes showed minimal complications. Based on the volumetric results, alveolar ridge preservation with d-PTFE membranes was superior to the bone graft alone in immediate implant placement.
Tooth decay, also known as caries, is a significant medical problem that harms teeth. Treatment is based on the removal of the carious material and then filling the cavity left in the tooth, most commonly with amalgam or composite resin. The consequences of filling failure include repeating the filling, or performing another treatment, such as a root canal, or extraction. Dental amalgam contains mercury, and there is a global effort to reduce its use. However, no consensus has been reached using randomized clinical trials, regarding whether amalgam or composite resin materials are more durable, and which is the best restorative material. To determine which material is superior, we performed a retrospective cohort study using a large database where members of the 58 dental clinics with 440 dental units were treated. The number of failures of the amalgam compared to composite resin restorations between 2014 and 2021 were compared. Our data included information from over 650,000 patients. Between 2014 - 2021, 260,905 patients were treated. 19,692 out of 113,281 first amalgam restorations failed (17.49%), whereas significantly fewer composite restorations failed (11.98%) 65,943 out of 555,671. This study indicates that composite is superior to amalgam and therefore it is reasonable to cease using mercury containing amalgam.
This study investigated the effect of platelet-rich fibrin (PRF) on bone healing around implants placed in elevated sinus cavities. Forty New Zealand albino rabbits were divided into eight groups, based on the time of sacrifice (14 or 40 days) and the material used: blood clot (control), hydroxyapatite (HA) from bovine bone, HA combined with PRF, and PRF alone. Each group consisted of five animals (n = 5). A histological analysis measured bone-to-implant contact (BIC) and bone area fraction occupancy (BAFO). The results showed significant increases in the BIC and BAFO values at 40 days compared to 14 days in most groups. At day 14, the HA+PRF group had higher BIC than the clot and the PRF alone groups. At 40 days, HA+PRF maintained the highest BIC across all groups (p < 0.05), though it did not show an advantage for BAFO. These findings indicate that combining HA with PRF promotes better osseointegration around implants placed immediately in maxillary sinus augmentation. Given the limited research on PRF’s biological impact, these results underscore the importance of evaluating PRF’s role in peri-implant healing and its potential benefits for clinical use in sinus augmentation.